Skip to main content
Figure 2 | Journal of Experimental & Clinical Cancer Research

Figure 2

From: Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type

Figure 2

Protective scores for the 23-miRNA signature and survival days in GBM patients with wild-type IDH1. A. Ranked protective scores. B. Survival days for the 140 GBM patients. C. The risky group and protective group for the 23 miRNAs. Risky miRNAs were expressed more in the high-risk group and protective miRNAs were expressed more in the low-risk group.

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us